Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-11

Clinical Trial Update: A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating alefacept for pityriasis rubra pilaris was terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amevive (alefacept)

Snippet

Sponsor: Joshua Zeichner | Conditions: Pityriasis Rubra Pilaris | Phase 4 | Status: TERMINATED | Results posted: 2018-05-11